Clinical Trials Sponsored by CV Therapeutics
Total 6340 results
-
Harbor TherapeuticsCompletedUlcerative ColitisUnited States
-
Sangamo TherapeuticsCompletedDiabetic NeuropathyUnited States
-
MediQuest TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
Cytori TherapeuticsCompletedBreast Neoplasms | Carcinoma, Ductal, Breast | Mammaplasty | Mastectomy, Segmental, Lumpectomy, Breast Reconstruction,Spain, United Kingdom, Belgium, Italy
-
Harbor TherapeuticsCompleted
-
Nile TherapeuticsCompletedAcute Decompensated Heart FailureUnited States, Germany, Israel
-
Ascenta TherapeuticsCompletedSmall Cell Lung CancerUnited States, Russian Federation, Ukraine
-
Capstone TherapeuticsTerminatedRadius FractureUnited States
-
Amicus TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Harbor TherapeuticsCompletedInsulin ResistanceUnited States
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Hypertension, PulmonaryUnited States
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
ARYx TherapeuticsUnknownMyocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic DiseaseUnited States
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaNetherlands
-
Aegera TherapeuticsTerminatedHuman Mammary CarcinomaUnited States
-
Alaunos TherapeuticsCompletedAdvanced CancerUnited States
-
vTv TherapeuticsCompletedEmbolism and Thrombosis | Hip Fractures | Venous ThromboembolismDenmark, Czech Republic, Norway, Sweden
-
MediQuest TherapeuticsUnknownFingernail PsoriasisUnited Kingdom
-
TorreyPines TherapeuticsCompletedSjogren's Syndrome | XerostomiaUnited States
-
Aegera TherapeuticsTerminated
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
ImaRx TherapeuticsTerminatedAcute Ischemic StrokeUnited States, France
-
Bayhill TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Introgen TherapeuticsUnknownCarcinoma, Squamous CellUnited States
-
Critical TherapeuticsCompleted
-
Aeris TherapeuticsTerminatedPulmonary EmphysemaIsrael
-
Aeris TherapeuticsCompletedPulmonary EmphysemaUnited States
-
Halozyme TherapeuticsCompleted
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Wellstat TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsCompletedHepatitis CRussian Federation
-
Point TherapeuticsCompleted
-
Point TherapeuticsCompleted
-
MediQuest TherapeuticsCompletedRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Autoimmune DiseaseUnited States
-
Cure TherapeuticsUnknown
-
Critical TherapeuticsTerminatedCoronary Disease | Heart Valve DiseasesUnited States
-
Wellstat TherapeuticsTerminatedSolid TumorsUnited States
-
CRISPR Therapeutics AGViaCyteRecruitingGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Melinta Therapeutics, LLCRecruitingGram Positive Bacterial InfectionsUnited States
-
TenNor Therapeutics LimitedCompletedGram-Positive Bacterial Infections | Skin and Subcutaneous Tissue Bacterial InfectionsUnited States
-
CRISPR Therapeutics AGViaCyteCompletedGlucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic DiseaseCanada
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Celldex TherapeuticsNot yet recruitingChronic Spontaneous Urticaria
-
PYC TherapeuticsNot yet recruitingEye Diseases | Retinal Degeneration | Retinal Dystrophies | Retinal Disease | Retinitis Pigmentosa 11United States
-
SURGE TherapeuticsNot yet recruiting
-
Celldex TherapeuticsNot yet recruitingChronic Spontaneous Urticaria